New York City time the next business day. The earliest expiration date for the Warrants remains August 19, 2025, subject to Enovix common stock continuing to trade above $10.50 for 20 of 30 trading days in accordance with the Warrant Agreement. Ryan Benton, Chief Financial Officer, stated, "We've now completed 14 consecutive trading days above $10.50 out of 20 within a 30 consecutive trading day period required to trigger early expiration. There may be only six trading days left prior to expiration of the Warrants, after which the Warrants will no longer be tradable or exercisable." As of August 7, approximately 6.1 million Warrants have been exercised, generating approximately $53.6 million in gross proceeds for the Company. Mr. Benton continued, "We've already received meaningful exercise notices from many of our shareholders. Every Warrant exercised supports our strategic priorities while preserving ownership for long-term shareholders.